2013
DOI: 10.1194/jlr.m041368
|View full text |Cite
|
Sign up to set email alerts
|

Molecular basis for differential elongation of omega-3 docosapentaenoic acid by the rat Elovl5 and Elovl2

Abstract: and Elovl2, which have been overlooked as regulators of DHA synthesis. Using a yeast expression system, it was apparent that the substrate specifi cities of the two rat elongases had some overlap, but that only Elovl2 could convert endogenously formed C 22 PUFA docosapentaenoic acid (DPA) (22:5n-3) to 24:5n-3, which is the penultimate precursor of DHA ( 5 ). Elovl2 performs the sequential elongation of EPA to DPA followed by further elongation to 24:5n-3.Thus, Elovl2 is crucial for DHA synthesis at least in th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
41
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(49 citation statements)
references
References 22 publications
3
41
1
Order By: Relevance
“…Elovl2 is required for synthesis of omega-3 docosahexaenoic acid (DHA; 22:6n-3), because this elongase (but not Elovl5) can elongate docosapentaenoic acid (22:5n-3) to 24:5n-3, a precursor of DHA. This difference in substrate specificity between Elovl2 and Elovl5 was shown to involve a region encompassing transmembrane domains 6 and 7, with a cysteine-to-tryptophan switch in transmembrane domain 7 proving particularly important in setting specificity (31).…”
Section: Discussionmentioning
confidence: 99%
“…Elovl2 is required for synthesis of omega-3 docosahexaenoic acid (DHA; 22:6n-3), because this elongase (but not Elovl5) can elongate docosapentaenoic acid (22:5n-3) to 24:5n-3, a precursor of DHA. This difference in substrate specificity between Elovl2 and Elovl5 was shown to involve a region encompassing transmembrane domains 6 and 7, with a cysteine-to-tryptophan switch in transmembrane domain 7 proving particularly important in setting specificity (31).…”
Section: Discussionmentioning
confidence: 99%
“…Provided the Gnathostomata (jawed fi sh) ancestral Fads2 had ⌬ 6 desaturase activity ( 32 ), as for mammalian FADS2s ( 35 ), the expansion of Fads2s in teleosts has been accompanied by subfunctionalization in the enzyme derived from independent mutations in the primary aa sequence ( 32 ). Although a recent study identifi ed a single aa residue as determining the differential ability for 22:5n-3 elongation between ELOVL2 and ELOVL5 elongases in rat ( 48 ), identifi cation of specifi c domains/residues controlling the functionality of desaturases has been elusive and studies are restricted to nonvertebrate enzymes (49)(50)(51). However, the above said, the existence of three ⌬ 6 ⌬ 5 desaturases and three ⌬ 4 desaturases distributed in four distinct species, allows us to explore potential evolutionary scenarios for teleostei Fads2 subfunctionalization.…”
Section: Discussionmentioning
confidence: 99%
“…The microarray data demonstrated a modest expression of ELOVL2 (averaging 20% in the tarsal plates of mice and 30% – in humans), but high expression levels of the gene in the livers of mice (about 80–85%) and humans (about 60%). The ELOVL2 enzyme catalyzes elongation of C 20 -C 22 polyunsaturated n-6 series FA with three or more double bonds, such as C 20 and C 22 polyunsaturated FA (Gregory et al, 2011); (Gregory et al, 2013a); (Okuda et al, 2010), but is also fairly active with C 14 -C 24 saturated substrates (Kitazawa et al, 2009). The low expression levels of ELOVL2/Elovl2 in TP of both species are consistent with our previous reports on the very small presence of its products in human and mouse meibum (Butovich, 2008; Butovich et al, 2012a; Butovich et al, 2007b; Butovich et al, 2009).…”
Section: A Concept Of Meibogenesismentioning
confidence: 99%